Resistance of fibrin clots to lysis in type 2 diabetes may also result from decreased binding of tissue plasminogen activator (t-PA) and plasminogen to fibrin, increased α2-antiplasmin cross-linking, [10] and increased glycation of plasminogen leading to lower plasmin generation and protein-specific activity [11]. The gene discussed is PLAT; the disease is type 2 diabetes mellitus.